Colistin versus colistin plus meropenem for severe infections reply

Research output: Contribution to journal › Article › Academic

2 Citations (Scopus)

Research programs

@article{89f2835f9890460da0649145833e3d49,

title = "Colistin versus colistin plus meropenem for severe infections reply",

author = "M Paul and Y Carmeli and GL Daikos and E Durante-Mangoni and U Theuretzbacher and Johan Mouton and L Leibovici",

year = "2018",

doi = "10.1016/S1473-3099(18)30223-8",

language = "Undefined/Unknown",

volume = "18",

pages = "495--496",

journal = "Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd.",

number = "5",

}

TY - JOUR

T1 - Colistin versus colistin plus meropenem for severe infections reply

AU - Paul, M

AU - Carmeli, Y

AU - Daikos, GL

AU - Durante-Mangoni, E

AU - Theuretzbacher, U

AU - Mouton, Johan

AU - Leibovici, L

PY - 2018

Y1 - 2018

U2 - 10.1016/S1473-3099(18)30223-8

DO - 10.1016/S1473-3099(18)30223-8

M3 - Article

C2 - 29695358

SN - 1473-3099

VL - 18

SP - 495

EP - 496

JO - Lancet Infectious Diseases

JF - Lancet Infectious Diseases

IS - 5

ER -